Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid

European Journal of Clinical Pharmacology

Volumn 64, Issue 10, 2008, Pages 1031-1032

  Cordoba, R ^a   Ramirez, E ^a   Lei, S H ^a   Lopez De La Guia, A ^a   Sanjurjo, M J ^a   Carcas, A J ^a   Hernandez Navarro, F ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CALCIUM; COTRIMOXAZOLE; CYTOCHROME P450 3A4; FUROSEMIDE; IDARUBICIN; ITRACONAZOLE; LINEZOLID; LORAZEPAM; METOCLOPRAMIDE; OMEPRAZOLE; RETINOIC ACID; ZOLEDRONIC ACID;

ADULT; CALCIUM BLOOD LEVEL; CASE REPORT; CHEMOTHERAPY; DRUG WITHDRAWAL; HUMAN; HYPERCALCEMIA; LETTER; LUNG DISEASE; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROPHYLAXIS; RETINOIC ACID SYNDROME;

ADULT; ANTINEOPLASTIC AGENTS; DIPHOSPHONATES; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; HYPERCALCEMIA; IMIDAZOLES; ITRACONAZOLE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; TREATMENT OUTCOME; TRETINOIN;

EID: 53249107734     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-008-0517-3     Document Type: Letter

References (10)

1. MA Sanz G Martín M González A León C Rayón C Rivas D Colomer E Amutio FJ Capote GA Milone J De La Serna J Román E Barragán J Bergua L Escoda R Parody S Negri MJ Calasanz P Bolufer 2004 Programa de Estudio y Tratamiento de las Hemopatías Malignas. Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group Blood 103 1237 1243
2. NA Rizvi JL Marshall E Ness J Yoe GM Gill JA Truglia GR Loewen D Jaunakais EH Ulm MJ Hawkins 1998 Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer Clin Cancer Res 4 6 1437 1442
3. MA Smith PC Adamson FM Balis J Feusner L Aronson RF Murphy ME Horowitz G Reaman GD Hammond RM Fenton 1992 Phase I and pharmacokinetic evaluation of all-trans retinoic acid in pediatric patients with cancer J Clin Oncol 10 11 1666 1673
4. MT Bennett S Sirrs JK Yeung CA Smith 2005 Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazole Leuk Lymphoma 46 1829 1831
5. T Niwa T Shiraga A Takagi 2005 Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes Biol Pharm Bull 28 9 1805 1808
6. M Sakakibara M Ichikawa Y Amano S Matsuzawa K Agematsu T Mori K Koike T Nakahata A Komiyama 1993 Hypercalcemia associated with all-trans retinoic acid in the treatment of acute promyelocytic leukemia Leuk Res 17 441 443
7. R Niesvisky DS Siegel X Busquets G Nichols J Muindi RP Warrel Jr J Michaeli 1995 Hypercalcemia and increased serum interleukin-6 levels induced by all-trans retinoic acid in patients with myeloma Br J Haematol 89 217 218
8. M Nagasawa H Okawa 1994 All-trans retinoic acid induced hypercalcemia in a patient with acute promyelocytic leukemia: its relation to increased PTH-rP Int J Hematol 59 2 143 412
9. Aguirre C (2004) Modified Karch-Lasagna algorithm. National Pharmacovigilance Agency of Spain. Causalidad en Farmacovigilancia. In: Rodríguez JM, Aguirre C (eds) Farmacovigilancia. Servicio editorial de la Universidad del País Vasco, Bilbao, p 93-98
10. O Sakamoto M Yoshinari T Rikiishi I Fujiwara M Imaizumi S Tsuchiya K Iinuma 2001 Hypercalcemia due to all-trans retinoic acid therapy for acute promyelocytic leukemia: a case report of effective treatment with bisphosphonate Pediatr Int 43 688 690